Side Effects of Injectable Weight Loss Drugs: What to Expect

The first few weeks: what your body is adjusting to

Picture the scenario most people describe: the first injection lands on a Sunday evening, and by Tuesday there's a low-grade queasiness that makes the smell of coffee feel like an affront. It's annoying. It's also, for most people, the worst it gets.

Both tirzepatide and semaglutide slow gastric emptying, food moves through the stomach more slowly, which is part of how they reduce appetite, and also why nausea is so common early on. The licensed schedule starts at a low dose precisely to give your system time to adapt before the amount increases. Eating smaller meals, avoiding very fatty foods, and staying hydrated all help; most people find the first week or two are the hardest, then things settle considerably.

Constipation tends to catch people off guard, it's often mentioned less than nausea but is just as common at certain doses. Increasing water intake and dietary fibre usually makes a meaningful difference. Diarrhoea and loose stools can also occur, particularly in the early weeks. Indigestion, reflux, burping and fatigue round out the most frequently reported effects. Injection-site reactions (redness or mild soreness where you inject) are also possible; rotating sites between your abdomen, thigh and upper arm reduces this. The weight loss injection process, including site rotation technique, is something our prescribers cover in aftercare.

None of this is guaranteed to happen to you. These are population-level patterns from clinical trials involving thousands of adults, individual experience varies considerably.

Side effects that go beyond nuisance and need prompt attention

Most of what people experience is unpleasant rather than dangerous. But there are specific symptoms that shouldn't be managed at home with ginger tea.

In January 2026, the MHRA published a Drug Safety Update specifically highlighting acute pancreatitis as a known, infrequent but serious risk with GLP-1 receptor agonists. The signal to watch for: severe, persistent abdominal pain that spreads to your back, with or without vomiting. If that happens, stop eating and drinking and get to A&E or call 999. Don't wait for it to pass on its own.

Gallbladder problems are another category worth knowing about. Symptoms (upper right abdominal pain, fever, jaundice) warrant a call to your GP or 111 rather than monitoring at home. Severe dehydration from persistent vomiting or diarrhoea can affect the kidneys; if you can't keep fluids down for more than a day, contact a healthcare professional.

Signs of a serious allergic reaction (swelling of the face or throat, difficulty breathing, rapid heartbeat) are rare but require 999 immediately. Any new or worsening low mood or thoughts of self-harm should prompt a call to your GP, 111 or Samaritans (116 123) without delay.

People using these medicines alongside insulin or other diabetes medications should be aware of the risk of low blood sugar; this is something a prescriber factors in before and during treatment. Our detailed side effects guide covers drug interaction considerations in more depth.

Injection-specific effects and practical ways to reduce them

Beyond the systemic effects, the injection itself can cause localised reactions: a raised lump, itching or bruising at the site. These are almost always mild and resolve on their own. Using a fresh needle for every dose matters, a blunt or previously used needle drags through tissue rather than passing cleanly, and that makes site reactions more likely. Letting the pen come to room temperature before injecting (rather than using it cold straight from the fridge) also reduces discomfort for many people.

Needle anxiety is real and worth saying plainly: the pen needles used with Mounjaro and Wegovy are short and fine, nothing like the clinical-looking syringes people often imagine. When the plain-packaged box arrives via DPD and you see the pen for the first time, most people find the reality much less daunting than the anticipation.

Injection technique questions (angle, depth, which sites to use) are covered by our prescribers during aftercare. If you're already using these medicines and have questions about technique, our support team is available seven days a week. For safe disposal, a sharps container is the right way to deal with used needles; standard household bins aren't appropriate.

If you're weighing up whether injectable treatment is right for you, our prescribers discuss side effects, your medical history and suitability as part of the free consultation, no obligation, no pressure.

Reporting side effects and staying safe throughout treatment

The MHRA's Yellow Card scheme is the UK's official system for reporting suspected side effects from any medicine, including tirzepatide and semaglutide. You can report as a patient, you don't need to go through a doctor. This matters: real-world reporting is how safety signals get detected after a medicine is licensed, and GLP-1 medicines carry a Black Triangle (▼) designation precisely because they're still accumulating post-market safety data.

If you purchased treatment through a pharmacy, you can also report concerns to them directly. At nume, a named prescriber reviews your case before every repeat order, not just the first one, so changes in how you're tolerating treatment get caught rather than continuing unchecked.

For a broader look at what the different injectable drugs for weight loss are and how they compare, that page covers the clinical landscape. If you're based in the Channel Islands, our page covering weight loss injections in Guernsey explains what's available and how to access treatment from there. For a fuller picture of what to expect throughout your course, our guide to the side effects of weight loss injections brings together everything covered here and more. For questions specific to getting a prescription through a regulated route, this guide on accessing weight loss injections explains what's involved.